TRINITY BIOTECH PLC - TRIB
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 06, 2026 | SCHEDULE 13G | Novus Diagnostics Ltd. | 5.99% | 1,119,988 | View |
| Jan 26, 2026 | SCHEDULE 13D/A | — | — | 1,877,081 | View |
| Dec 23, 2025 | SCHEDULE 13D/A | — | 97.0% | 1,877,081 | View |
| Dec 15, 2025 | SCHEDULE 13D/A | — | — | — | View |
| Dec 10, 2025 | SCHEDULE 13D/A | — | 17.0% | 44,759,380 | View |
| Dec 04, 2025 | SCHEDULE 13D/A | — | 100.0% | 44,759,380 | View |
| Oct 24, 2025 | SCHEDULE 13D/A | — | 9.99% | — | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.